Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study

Introduction: Effective (neo) adjuvant chemotherapy for cholangiocarcinoma is lacking due to chemoresistance and the absence of predictive biomarkers. Human equilibrative nucleoside transporter 1 (hENT1) has been described as a potential prognostic and predictive biomarker. In this study, the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyd, Lenka N. C., Nooijen, Lynn E., Ali, Mahsoem, Puik, Jisce R., Moustaquim, Jasmine, Fraga Rodrigues, Stephanie M., Broos, Robert, Belkouz, Ali, Meijer, Laura L., Le Large, Tessa Y. S., Erdmann, Joris I., Hooijer, Gerrit K. J., Heger, Michal, Van Laarhoven, Hanneke W. M., Roos, Eva, Kazemier, Geert, Giovannetti, Elisa, Verheij, Joanne, Klümpen, Heinz-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619907/
https://www.ncbi.nlm.nih.gov/pubmed/37920204
http://dx.doi.org/10.3389/fphar.2023.1274692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619907/
https://www.ncbi.nlm.nih.gov/pubmed/37920204
http://dx.doi.org/10.3389/fphar.2023.1274692

Ejemplares similares